Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced the ...

Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherap ...

“With this latest expansion, Vetscan Imagyst becomes the only commercially available veterinary diagnostic tool of its kind ...

Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk ...

A doctor who beat stage 4 colon cancer has shared three symptoms of the disease she noticed before she was diagnosed, but ...

Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as ...

Lauren Juyia, a gynaecologist who survived stage 4 colon cancer, has shared three of the symptoms she spotted before she was ...

Dear Abby helps a reader with a neighbor's cat that keeps waking them up, along with a reader who has prostate cancer, and ...

A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...

Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand ...

A lockdown hobby that turned into a new business for Wesham mum and hairdresser Karen “Kaz” Cope, who lost her life to cancer ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...